Santa Cruz Biotechnology retweeted
Here's a reminder on #InternationalCoffeeDay: It's OK to take a (coffee) break. ☕
"It’s ... helpful to have a venue to share the day-to-day ups and downs of life as a grad student." scim.ag/4hiS233
ALT People arm in arm while drinking coffee and holding papers, with the headline: Why scientists should take more coffee breaks
Santa Cruz Biotechnology retweeted
Until recently, no one had seen DNA voyaging between human cells along intercellular highways called tunneling nanotubes. sciencenews.org/article/dama…
Santa Cruz Biotechnology retweeted
Researchers have replaced much of a mouse cortex with neurons grown from human stem cells.
These chimeric brains were created by genetically engineering rodents to prevent the development of parts of the mouse brain and transplanting 3D blobs of human tissue called organoids in their place.
By allowing scientists to observe how human cells develop and work as part of an intact nervous system—something not possible by growing organoids in a dish—this mouse model could reveal underlying biological causes of disease and even point to potential treatments.
Learn more: scim.ag/4yaUwGz
ALT Human neurons flourish in mouse brains, offering a new view of neurodevelopmental disorders
Santa Cruz Biotechnology retweeted
A new #SciencePerspective highlights the strengths and challenges of “self-driving” laboratories, spaces that combine robotics, high-throughput experiments, AI, and automated analysis to transform scientific discovery.
Read more: scim.ag/3U6EM8z
Santa Cruz Biotechnology retweeted
Scientists have created the first comprehensive map of the human vagus nerve, tracing thousands of individual nerve fibers stretching from the lower brain stem to all major organs.
The map might help scientists and doctors more precisely stimulate the nerve as a potential treatment for conditions such as epilepsy, stroke, and inflammatory diseases.
Learn more: scim.ag/4wiOIZI @NewsfromScience
Santa Cruz Biotechnology retweeted
The foodborne illness cyclosporiasis has exploded in the United States this summer: More than 6700 cases have been confirmed and more than 11,500 potential ones have been reported to the CDC by 45 states between 1 May and 28 July.
However, due to the parasite’s biology, combined with logistical issues and budget cuts at CDC, figuring out where all those infections came from has been a struggle.
Learn more: scim.ag/4yLVPwj @NewsfromScience
ALT Why is tracing the source of cyclosporiasis outbreaks so difficult?
Santa Cruz Biotechnology retweeted
Scientists isolate a bacteriophage that switches off a key virulence mechanism in adherent #Ecoli that drive Crohn’s disease, and can attenuate colitis in mice and augment the efficacy of low doses of budesonide. @ScienceTM scim.ag/4aOAd8l
Santa Cruz Biotechnology retweeted
Scientists have untangled the nuanced, tissue-specific effects of allosteric compounds that activate the fatty acid receptor FFAR2—findings that could inform the design of more selective therapeutics. @SciSignal scim.ag/4eYZKNm
Santa Cruz Biotechnology retweeted
Key human defenses against pathogens were forged billions of years ago in microbial battles with viruses.
Learn more: scim.ag/49pOrM8 @NewsfromScience
Santa Cruz Biotechnology retweeted
🚨 TINY ROBOTS COULD SOON TREAT STROKES FROM INSIDE THE BODY
Scientists have developed microscopic robots that can travel through blood vessels and deliver medicine directly to a blood clot. Guided by magnetic fields, these tiny capsules release drugs exactly where they are needed, potentially making stroke treatment safer and more effective.
In preclinical tests, the robots reached their target more than 95% of the time, offering a fascinating glimpse into the future of precision medicine.
Source:
ETH Zurich. Microrobots for targeted drug delivery and future stroke treatment research.
ALT 🚨 TINY ROBOTS COULD SOON TREAT STROKES FROM INSIDE THE BODY Scientists have developed microscopic robots that can travel through blood vessels and deliver medicine directly to a blood clot. Guided by magnetic fields, these tiny capsules release drugs exactly where they are needed, potentially making stroke treatment safer and more effective. In preclinical tests, the robots reached their target more than 95% of the time, offering a fascinating glimpse into the future of precision medicine. Source: ETH Zurich. Microrobots for targeted drug delivery and future stroke treatment research.
Santa Cruz Biotechnology retweeted
In a major medical breakthrough, South Korean scientists have successfully implanted the world’s first 3D-printed windpipe made entirely from a patient’s own cells.
The groundbreaking procedure was performed on a woman who had lost part of her trachea after thyroid cancer surgery. Using advanced bioprinting technology, researchers created a personalized windpipe by combining the patient’s own living cells with a biodegradable scaffold.
Because the implant was made from her own biological material, her body recognized it as natural tissue. This resulted in zero rejection and eliminated the need for lifelong immune-suppressing drugs — a common requirement in traditional organ transplants.
The successful integration marks a significant step forward in regenerative medicine and personalized organ replacement.
Santa Cruz Biotechnology retweeted
Of the hundreds of types of amino acids found on Earth, it’s a mystery why life settled on 20 as the building blocks for all its proteins. Although certain species can use more—some microbes employ up to 22—no one’s ever found one using fewer.
But now scientists are closer to creating such an organism, after partially eliminating one of the 20 amino acids from the bacterium Escherichia coli.
The research used #AI to propose alternatives to the amino acid isoleucine in dozens of proteins making up bacterial ribosomes—the protein factories of the cell.
The findings offer a glimpse into how earlier, simpler life forms might have lived and suggest new ways to synthesize proteins with bespoke functions in medicine and biotechnology.
Learn more: scim.ag/4wifwLc @NewsfromScience
Santa Cruz Biotechnology retweeted
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments mainstream. #Forbes250
Forbes has named Doudna to our list of America’s 250 Greatest Innovators.
Read the full story on the Nobel laureate: forbes.com/sites/amyfeldman/…
Santa Cruz Biotechnology retweeted
🚨 Breaking Cancer News
Imagine this: doctors inject one tumor, and suddenly the body’s immune system starts attacking cancer everywhere. Not just the tumor that got the shot, all tumors in the body. Sounds like science fiction… but early trials suggest it’s real.
A redesigned CD40 immunotherapy is being tested. Instead of giving the drug through the bloodstream (which caused severe side effects before), scientists inject it directly into a single tumor. That tumor acts as a training ground for the immune system. Immune cells learn to recognize the cancer and then hunt down other tumors throughout the body.
In a small trial of 12 patients with metastatic cancers, six saw their tumors shrink, and two experienced complete disappearance of all detectable cancer. Minimal side effects were reported. One injection, whole-body response — a possible game-changer for cancer treatment.
Source: ScienceDaily. (2026, March 15). Inject one tumor, immune system attacks all: Early trial shows promise for redesigned cancer therapy.
Santa Cruz Biotechnology retweeted
Imagine if a nasal spray could make you immune not only to the viruses that cause COVID-19 and influenza, but to all respiratory diseases
go.nature.com/3MsJ3jb
Santa Cruz Biotechnology retweeted
@CRISPR_News is positioned in the medical industry, focusing on the anti-aging and longevity niche.
The narrative around the longevity industry has been gaining significant momentum, with multiple high-profile figures investing heavily in the field.
$CRSP has been range-bound since 2021 but is finally showing signs of increased activity. Heightened volume, paired with local market structure shifts, indicates accumulation by larger players.
The $40–$45 region represents a strong pocket of liquidity and demand that could fuel the next leg higher and potentially lead to an aggressive breakout.
Santa Cruz Biotechnology retweeted
Imaging-based CRISPR genome screening allows effects of cell-regulating molecules & modifications to be revealed in live & fixed cells – applied here to frog embryo cilia
📹 Jingbo Sun et al @DavidBreslowLab @Yale in @Dev_Cell
➡️ bpod.org.uk/archive/2026/1/2…
Santa Cruz Biotechnology retweeted
You don’t need a brain to benefit from a good night of sleep. Despite lacking a central nervous system, jellyfish and sea anemones have sleep patterns remarkably similar to those of humans, researchers report.
Learn more: scim.ag/49qn4k2
Santa Cruz Biotechnology retweeted
MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors and destroy them. news.mit.edu/2025/turning-im…
Santa Cruz Biotechnology retweeted
These cells could be a fresh target for treating Alzheimer's disease and memory conditions associated with PTSD
go.nature.com/3W7aro4
